Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.

por Tim Muilwijk, Murat Akand, Sofie Daelemans, Koen Marien, Yannick Waumans, Mark Kockx, Loïc Baekelandt, Thomas Van den Broeck, Frank Van der Aa, Thomas Gevaert, Steven Joniau
Publicado 2021